Michael Hoosien, MD
Clinical Cardiac Electrophysiology · Atlanta, GANPI 1134362627
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Johnson & Johnson at 40.9% of the total. Reporting peaked in 2019 at $11,388 and has fallen 67.8% since, to $3,667 in 2025.
Across 645 payments — averaging $57.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$15K
- Biosense Webster, Inc.$6K
- Atricure, Inc.$4K
- Medtronic$3K
- Cvrx, Inc.$3K
- Biotronik Inc.$2K
- plus $4K from 26 others
Across 32 payments — averaging $2994.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cvrx, Inc.$43K
- Janssen Research & Development, LLC$30K
- Abbott$22K
What the payments were for
- Consulting fees$2,1746%
- Speaking & faculty fees$13,78537%
- Travel & lodging$5,90116%
- Food & beverage$15,40941%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 55 | $15,227 |
| Biosense Webster, Inc. | 368 | $6,361 |
| Atricure, Inc. | 33 | $3,541 |
| Medtronic(2 entities) | 35 | $3,413 |
| Cvrx, Inc. | 27 | $2,809 |
| Biotronik Inc. | 5 | $1,850 |
| Abbott | 30 | $1,035 |
| Boston Scientific | 21 | $921 |
| EBR Systems, Inc. | 6 | $536 |
| Cardiva Medical, Inc. | 11 | $245 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $220 |
| ZOLL Respicardia, Inc. | 1 | $166 |
| Acutus Medical, Inc. | 9 | $160 |
| Cordis US CORP. | 4 | $92 |
| E.r. Squibb & Sons, L.L.C. | 5 | $91 |
| Impulse Dynamics (USA) Inc. | 5 | $91 |
| Inspire Medical Systems, Inc. | 2 | $81 |
| Edwards Lifesciences | 2 | $67 |
| Pfizer | 3 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Portola Pharmaceuticals, LLC | 2 | $40 |
| Baxter Healthcare | 2 | $34 |
| Novartis | 2 | $32 |
| Philips North America LLC | 1 | $27 |
| AstraZeneca | 1 | $25 |
| Vektor Medical Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Cardiofocus, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Amgen | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$14,668
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$2,410
- Barostim Neo System$2,362
- Micra$1,181
- SPHERE-9$471
- SYNERGY ABLATION SYSTEM$465
- Carto 3$422
- Carto 3 System$341
- Solia$336
- BioMonitor$336
- Acticor 7 VR-T DX$336
- Selectra$336
- AMVIA EDGE$336
- ATRICLIP LAA EXCLUSION SYSTEM$294
- AVEIR$203
- PulseSelect$184
- Quadra Assura CRT Defibrillator$179
- remede System$166
- FARAWAVE$145
- QDOT MICRO Catheter$143
How this compares
$37,273 in reported general payments places this provider in the 65th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 547 | $629,240 |
| XareltoRivaroxaban | 138 | $142,979 |
| Dofetilide | 185 | $31,931 |
| MultaqDronedarone Hcl | 20 | $16,773 |
| Flecainide Acetate | 379 | $14,069 |
| Propafenone Hcl ErPropafenone Hcl | 32 | $5,475 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 204 | $4,314 |
| Metoprolol Succinate | 287 | $3,416 |
| SotalolSotalol Hcl | 122 | $2,332 |
| Amiodarone Hcl | 165 | $1,681 |
| Digoxin | 16 | $441 |
| Propafenone Hcl | 17 | $422 |
| Metoprolol Tartrate | 56 | $343 |
| Pantoprazole Sodium | 55 | $317 |
| Carvedilol | 29 | $235 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $42 | $629,240547 claims |
| Johnson & JohnsonXarelto | $15,227 | $142,979138 claims |
| Sanofi-aventis U.S. LLCMultaq | $42 | $16,77320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Atlanta
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- Michael LloydAtlanta$221K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Bruce StamblerAtlanta$91K
- Stacy WestermanAtlanta$60K
- Ashish BhimaniAtlanta$51K
- Aaron RichardsonAtlanta$51K
- Devinder DhindsaAtlanta$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.